| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.094 | 0.09 |